Apoptosis, heart failure, ischemic heart disease

Heart Failure Reviews

Volumn 4, Issue 2, 1999, Pages 165-173

  Maulik, Nilanjana ^a   Das, Dipak K ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Antioxidants; Apoptosis; Free radicals; Heart failure; Ischemia reperfusion; Phospholipids

Indexed keywords

ANTIOXIDANT; CALCIUM DERIVATIVE; CAPTOPRIL; DNA; FREE RADICAL; NITRIC OXIDE; OXYGEN RADICAL; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLSERINE; PHOSPHOLIPID; PROTEIN BAX; PROTEIN BCL 2; SCAVENGER; TUMOR NECROSIS FACTOR;

APOPTOSIS; CARDIOMYOPATHY; DOG; HEART FAILURE; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE REPERFUSION; HUMAN; ISCHEMIC HEART DISEASE; KNOCKOUT MOUSE; PHOSPHORYLATION; RABBIT; RAT; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SWINE; TRANSGENIC MOUSE;

EID: 0032858889     PISSN: 13824147     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (70)

1. Kaufmann SH, ed. Apoptosis: Pharmacological Implications and Therapeutic Opportunities, 1st ed, Vol. 41. San Diego: Academic Press, 1997.
2. Yao M, Keogh A, Spratt P, dos Remedios CG, KieBling PC. Elevated Dnase I levels in human idiopathic dilated cardiomyopathy: An indicator of apoptosis? J Mol Cell Cardiol 1996;28:95-101.
3. Barr PJ, Tomei LD. Apoptosis and its role in human disease. Biotechnology 1994;12:487-493.
4. Jennings RB, Sommers HM, Kaltenbach JP, West JJ. Electrolyte alterations in acute myocardial ischemic injury. Circ Res 1964;14:260-269.
5. Das DK, Maulik N, Moraru II. Gene expression in acute myocardial stress. Induction by hypoxia, ischemia/reperfusion, hyperthermia and oxidative stress. J Mol Cell Cardiol 1995;27:181-193.
6. Dec GW. Prognosis in congestive heart failure: What information can best predict the future? J Nucl Med 1992;33:477-479.
7. Sabbah HN, Sharov VG, Riddle JM, Kono T, Lesh M, Goldstein S. Mitochondrial normalities in myocardium of dogs with chronic heart failure. J Mol Cell Cardiol 1992;24: 1333-1347.
8. Reimer KA, Jennings RB. Ion and water shifts, cellular. In: Cowley RA, Trump BF, eds. Pathophysiology of Shock, Anoxia, and Ischemia. Baltimore: Williams and Wilkins, 1982;132-146.
9. 2+ in toxic cell killing. Trends Pharmaco Sci 1989; 10:281-285.
10. Gottlieb RA, Burleson KO, Kloner RA, Babior BM, Engler RL. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clinic Invest 1994;94:1621-1628.
11. Tanaka M, Ito H, Adachi S, Akimoto H, Nishikawa T, Kasajima T, Marumo F, Hiroe M. Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes. Circ Res 1994;75: 426-433.
12. Sharov VG, Sabbah HN, Shimoyama H. Evidence of cardiomyocyte apoptosis in myocardium of dogs with chronic heart failure. Am J Pathol 1996;148:141-149.
13. Sharov VG, Goussev A, Higgins RSD. Higher incidence of cardiocyte apoptosis in failed explanted hearts of patients with ischemic versus idiopathic dilated cardiomyopathy. Circulation 1997;96(Abstract):1-17.
14. Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara JA, Quaini E, Loreto CD, Beltrami CA, Krajewski S, Reed JC, Anversa P. Apoptosis in the failing human heart. N Engl J Med 1997;336:1131-1141.
15. Narula J, Haider N, Virmini R, Disalvo TG, Kolodgie FD, Hajjar RJ, Schmidt U, Semigran MJ, Dec G W, Khaw BA. Apoptosis in myocytes in end-stage heart failure. N Engl J Med 1996;335:1182-1189.
16. Liu Y, Cigola E, Cheng W, Kajstura J, Olivetti G, Hintze TH, Anversa P. Myocyte nuclear mitotic division and programmed myocyte nuclear mitotic division and programmed myocyte cell death characterize the cardiac myopathy induced by rapid ventricular pacing in dogs. Lab Invest 1995;73:771-787.
17. Packer M. Is tumor necrosis factor an important neurohormonal mechanism in chronic heart failure? Circulation 1995;95:1379-1382.
18. Aoki N, Siegfried M, Lefer AM. Anti-EDRF effect of tumor necrosis factor in isolated perfused carotid arteries. Am J Physiol 1989;256:H1509-H1512.
19. Matsubara T, Ziff M. Increased superoxide anion release from human endothelial cells in response to cytokines. J Immunol 1986;137:3259-3298.
20. Habit FM, Springal DR, Davies GJ, Oakley CM, Yacub MN, Polak JM. Tumor necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy. Lancet 1996;347:1151-1154.
21. Hatwood GA, Tsao PS, Von Der Leyen, Mann MJ, Keeling PJ, Trindade PT, Lewis NP, Byrne Cd, Rickenbacher PR, Bishopric NH, Cooke JP, Mckenna WJ, Fowler MB. Expression of inducible nitric oxide synthase in human heart failure. Circulation 1996;93:1087-1094.
22. Ferrari R, Agnoletti L, Comini L, Gaia G, Bachetti T, Cargnoni A, Ceconi C, Curello S, Visioli O. Oxidative stress during myocardial ischemia and heart failure. Eur Heart J 1998;19:B2-B11.
23. Hegewisch S, Weh HJ, Hossfeld DK. TNF-induced cardiomyopathy. Lancet 1990;2:294-295.
24. Wong SC, Fukuchi M, Melnyk P, Rodger I, Giaid A. Induction of cyclooxygenase-2 and activation of nuclear factor-kappa B in myocardium of patients with congestive heart failure. Circulation 1998;98:100-103.
25. Zhihe Li, Bing OHL, Long X, Robinson KG, Lakatta EG. Increased cardiomyocyte apoptosis during the transition heart failure in the spontaneously hypertensive rat. Am J Physiol 1997;272:H2313-H2319.
26. 2+: Their relationship to apoptosis and oncogenesis. FEBS Lett 1993;325:104-107.
27. Greenlund LJS, Deckwerth TL, Johnson EM Jr. Superoxide dismutase delays neuronal apoptosis: A role for reactive oxygen species in programmed neuronal death. Neuron 1995;14:303-315.
28. Tominaga T, Kure S, Narisawa K, Yoshimoto T. Endonuclease activation following focal ischemic injury in the rat brain. Brain Res 1993;608:21-26.
29. Fukuda K, Kojiro M, Chiu JF. Demonstration of extensive chromatin cleavage in transplanted Morris Hepatoma 7777 tissue: Apoptosis or necrosis. Am J Pathol 1993; 142:935-946.
30. Schumer M, Colombel MC, Sawczuk IS, Gobe G, Connor J, O'Toole KM, Wise GJ, Buttyan R. Morphologic, biochemical & molecular evidence of apoptosis during the reperfusion phase after brief periods of renal ischemia. Am J Pathol 1992;140:831-838.
31. Kajstura J, Cheng W, Reiss K, Clark WA, Sonnenblick EH, Krajewski S, Reed JC, Olivetti G, Anversa P. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest 1996;74:86-107.
32. Isner JM, Kearney M, Bortman S, Passeri J. Apoptosis in human atherosclerosis and restenosis. Circulation 1995;91:2703-2711.
33. Maulik N, Yoshida T, Das DK. Oxidative stress developed during reperfusion of ischemic myocardium induces apoptosis in rat heart. Free Rad Biol Med 1998;24:869-875.
34. Maulik N, Kagan EV, Das DK. Translocation of phosphatidylserine and phosphatidylethanolamine precedes apoptosis in ischemic reperfused heart. Am J Physiol 1998;274:H242-H248.
35. Fliss H, Gattinger D. Apoptosis in ischemic and reperfused rat myocardsium. Circ Res 1996;79:949-956.
36. Maulik N, Yoshida T, Das DK. Regulation of cardiomyocyte apoptosis in ischemic reperfused mouse heart by glutathione peroxidase. Mol Cell Biochem 1999;196:13-21.
37. Sharov V, Sabbah H N, Shimoyama H, Goussev A V, Lesch M, Goldstein S. Evidence of cardiocyte apoptosis in myocardium of dogs with chronic heart failure. Am J Pathol 1996;148:141-149.
38. Flack J, Kimura Y, Engelman RM, Das DK. Preconditioning the heart by repeated stunning improves myocardial salvage. Circulation 1991;84:III369-III374.
39. Li GC, Vasquez BS, Gallagher KP, Lucchesi BR. Myocardial protection with preconditioning. Circulation 1990;82: 609-619.
40. Maulik N, Goswami S, Galang N, Das DK. Differential regulation of BCL-2, AP-1 and NF-kB on cardiomyocyte apoptosis during myocardial ischemic stress adaptation. FEBS Lett 1999;443:331-336.
41. Das DK, Maulik N, Sato M, Ray P. Reactive oxygen species function as second messenger during ischemic preconditioning of heart. Mol Cell Biochem 1999;196:59-67.
42. Geldwerth DFA, Kuypers FA, Butikofer P, Allary M, Lubin BH, Devaux PF. Transbilayer mobility and distribution of red cell phospholipids during storage. J Clin Invest 1993;92:308-314.
43. Morrot G, Zachowski A, Devaux PF. Partial purification and characterization of the human erythrocyte Mg2+-ATPase: A candidate aminophospholipid translocase. FEBS Lett 1990;266:29-32.
44. Das DK, Engelman RM, Prasad MR, Rousou JA, Breyer RH, Jones R, Young H, Cordis GA. Improvement of ischemia reperfusion induced myocardial dysfunction by modulating calcium overload using a novel specific calmodulin antagonist, CGS 9343B. Biochem Pharmacol 1989;38:465-471.
45. Post JA, Langer GA, Op den Kamp JA, Verkleij AJ. Phospholipid asymmetry in cardiac sarcolemma. Analysis of intact cells and gas-dissected membranes. biochem Biophys Acta 1988;943:255-266.
46. Koopman G, Reutelingsperger CP, Kuijten GA, Keehen RM, Pals ST, Van Oers MH. Annexin V for flow cytometric detection of phosphatidylserin expression on B cells undergoing apoptosis. Blood 1995;84:1415-1420.
47. Verhoven B, Schlegel RA, Williamson P. Mechanisms of phosphatidylserine exposure, aphagocyte recognition signal, on apoptotic T lymphocytes. J Exp Med 1995; 182:1597-1601.
48. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidyleserine expression on early apoptotic cells using fluoresceine labeled annexin V. J Immunol Methods 1995;184:39-51.
49. Buttke TM, Sandstrom PA. Oxidative stress as a mediator of apoptosis. Immunol Today 1994;15:7-10.
50. Verity MA, Bredesen DE, Sarafian T. Role of reactive oxygen species in neuronal degeneration. Annals NY Acad Sci 1995;765:340.
51. Muehlematter D, Larsson R, Cerutti P. Active oxygen induced DNA strand breakage and poly ADP-ribosylation in promotable and non-promotable JB6 mouse epidermal cells. Carcinogenesis 1988;9:239-245.
52. Noguchi N, Yoshida Y, Kaneda H, Yamamoto Y, Niki E. Action of ebselen as an antioxidant against lipid peroxidation. Biochem Pharmacol 1992;44:39-44.
53. Ramakrishnan N, Kalinich JF, McClain DE. Ebselen inhibition of apoptosis by reduction of peroxides. Biochem Phartmacol 1996;51:1443-1451.
54. Maulik N, Sato M, Price BD, Das DK. An essential role of NFκB in tyrosine kinase signaling of p38 MAP kinase regulation of myocardial adaptation to ischemia. FEBS Lett 1998;429:365-369.
55. McMahon SB, Monroe JG. Role of primary response genes in generating cellular responses to growth factors. FASEB J 1992;62:2707-2715.
56. Diamond MI, Miner JN, Yoshinaga SK, Yamamoto KR. Transcription factor interactions: Selectors of positive or negative regulation from a single DNA element. Science 1990;249:1266-1272.
57. Ham J, Babij C, Whitfield J, Pfarr C M, Lallemand D, Yaniv M, Rubin LL. A c-Jun dominant negative mutant protects sympathetic neurons against programmed cell death. Neuron 1995;14:927-937.
58. Das DK, Engelman RM, Kimura Y. Molecular adaptation of cellular defences following preconditioning of the heart by repeated ischemia. Cardiovasc Res 1993;27:578-584.
59. Brand T, Sharma HS, Fleishmann KE, Duncker DJ, McFalls EO, Verdouw PD, Schaper W. Proto-oncogene expression in porcine myocardium subjected to ischemia and reperfusion. Circ Res 1992;71:1351-1360.
60. Maulik N, Yoshida T, Engelman RM, Rousou JA, Flack J E, Deaton D, Das D K. Oxidative stress developed during reperfusion of ischemic myocardium downregulates Bcl-2 gene and induces apoptosis and DNA laddering. Surg Forum 1997;48:245-249.
61. Hokenbery DM, Oltvai ZN, Yin X-M, Milliman CL, Korsmeyer XY. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993;75:241-251.
62. Maulik N, Engelman RM, Rousou JA, Flack JE, Deaton DW, Das DK. Ischemic preconditioning supresses apoptosis by upregulating the anti-death gene, Bcl-2. Surg Forum 1998;49:209-211.
63. Marti A, Jehn B, Costello E, Keon N, Ke G, Martia F, Jaggi R. Protein kinase A and AP-1 (c-Fos/Jun D) are induced during apoptosis of mouse mammary epithelial cells. Oncogene 1994;9:1213-1223.
64. Sawai H, Okazaki T, Yamamoto H, Okano H, Takeda Y, Tashima M, Sawada H, Okuma M, Ishikura H, Umehara H, Domae N. Requirement of AP-1 for ceramide-induced apoptosis in human leukemia HL-60 cells. J Biol Chem 1995;270:27326-27331.
65. Watabe M, Ito K, Masuda Y, Nakajo S, Nakaya K. Activation of AP-1 is required for bufalin-induced apoptosis in human leukemia U937 cells. Oncogene 1998;16:779-787.
66. Ishikawa Y, Yokoo T, Kitamura M. C-Jun/AP-1, but not NFkB, is a mediator for oxidant-initiated apoptosis in glomerular mesangial cells. Biochem Biophys Res Commun 1997;240:496-501.
67. Toledano M, Leonard WJ. Modulation of transcription factor NF-kappa B binding activity by oxidation-reduction in vitro. Proc Natl Acad Sci USA 1991;86:5974-5978.
68. Meyer M, Schreck R, Baeuerle PA. H202 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J 1993;12:2005-2015.
69. Maulik N. Apoptotic cell death during ischemia/reperfusion and its attenuation by antioxidant therapy. J Cardiol Pathol 1999; In press.
70. Maulik N, Yoshida T, Engelman RM, Rousou JA, Flack JE, Deaton D, Das DK. Oxidative stress developed during open heart surgery induces apoptosis: Reduction of apoptotic cell death by free radical scavenger, Ebselen (Abstract). Circulation, 1997.